Each month, the Geographic Health Equity Alliance (GHEA) aggregates the latest news and research related to place-based cancer control and geographic health disparities. Below you will find the latest posts, updated regularly throughout the month.
(Last updated: April 22, 2021)
Place-Based Cancer Control News and Research
- A recent article highlights the financial barriers that could prevent advancing research at rural hospitals.
General Cancer Control News and Research
- A study on the changes in mammography utilization during the COVID-19 pandemic finds that overall monthly mammography counts rebounded strongly between June and July 2020 following extremely low counts between March and May 2020.
- The American Journal of Gastroenterology recently updated their colorectal cancer screening guidelines. The updated guidelines include recommendations for average-risk individuals and those with a family history of colorectal cancer (CRC). Additional topics include the role of aspirin for chemoprevention, quality indicators for colonoscopy, approaches to organized CRC screening and improving adherence to CRC screening.
- A research study finds that a heart-healthy lifestyle can help lower your risk of developing cancer, as well as preventing heart disease.
- Researchers find that cancer survivors with chronic musculoskeletal pain receiving electroacupuncture and auricular acupuncture had significantly greater pain reduction compared with patients receiving usual care.
- The American College of Surgeons Commission on Cancer has joined a nationwide effort to encourage patients to resume appropriate cancer screening to prevent a more extensive illness or excess deaths.
- A research study on the relationship between menopausal hormone therapy (MHT), mammographic density and breast cancer risk finds that nearly half of the effect of MHT on hormone receptor-positive BC risk is mediated by mammographic density, which appears to be modified by MHT for up to eight years after MHT termination.
- A study on the enhanced recovery after surgery (ERAS) protocol found that ERAS protocol for gynecologic oncology patients undergoing interval cytoreductive surgery is associated with a timely return to the intended oncology treatment.
- Scientists have genetically engineered immune cells, called myeloid cells, to precisely deliver an anticancer signal to organs where cancer may spread. In an experimental study on mice, treatment with the engineered cells shrank tumors and prevented the cancer from spreading to other parts of the body.